Management of influenza in primary care practices

被引：0

作者：

Vogel, GE

Heckler, R

Komm, C

Schöttler, M

Lange, R

Lange, W

Wutzler, P

机构：

[1] Practice Internal Med Gastroenterol & Nephrol, D-80638 Munich, Bavaria, Germany

[2] Inst Radiol, Munich, Germany

[3] NLGA, DGVI, Hannover, Germany

[4] Hoffmann La Roche Ag, Grenzach Wyhlen, Germany

[5] Heart Surg, Munich, Germany

[6] DGVI RealFlu, Berlin, Germany

[7] Inst Antiviral Chemotherapy, Jena, Germany

来源：

OPTIONS FOR THE CONTROL OF INFLUENZA V | 2004年 / 1263卷

关键词：

influenza; neuraminidase inhibitors; diagnosis; C-reactive protein; complications;

D O I：

10.1016/j.ics.2004.02.064

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

The neuraminidase inhibitors (NI) Oseltamivir and Zanamivir are a valuable supplementation to vaccines for the control and prevention of influenza. To support the appropriate clinical use of these new antiviral drugs, guidelines have been developed in Germany. A prerequisite for an accurate clinical diagnosis is that the physicians obtain actual information on the epidemic situation, particularly in their region. Reliable, real-time information can be provided by the newly developed surveillance system, RealFlu(TM). The results of an evaluation of 99 NI-treated influenza patients and their medical laboratory values are presented. (C) 2004 Published by Elsevier B.V..

引用

页码：499 / 502

页数：4

共 50 条

[31] Influenza-attributable burden in United Kingdom primary care
Fleming, D. M.
Taylor, R. J.
Haguinet, F.
Schuck-Paim, C.
Logie, J.
Webb, D. J.
Lustig, R. L.
Matias, G.
EPIDEMIOLOGY AND INFECTION, 2016, 144 (03) : 537 - 547
[32] Antiviral treatment and prophylaxis of influenza in primary care:: German recommendations
Wutzler, P
Kossow, KD
Lode, H
Ruf, BR
Scholz, H
Vogel, GE
Ehlers, M
Färber, I
Fock, R
Gillissen, A
Heckler, R
Höffken, G
Kossow, KD
Lode, H
Lüdke, HW
Ruf, BR
Schade, S
Scholz, H
Schmidt, RE
Ruf, BR
Schade, S
Scholz, H
Schmidt, RE
Skopnik, H
Vogel, GE
Wutzler, P
JOURNAL OF CLINICAL VIROLOGY, 2004, 31 (02) : 84 - 91
[33] Tackling Disparities in Influenza Vaccination in Primary Care: It Takes a Team
Kevin Fiscella
Journal of General Internal Medicine, 2014, 29 : 1579 - 1581
[34] Management of osteoporosis in primary care in Australia
Chen, J. S.
Hogan, C.
Lyubomirsky, G.
Sambrook, P. N.
OSTEOPOROSIS INTERNATIONAL, 2009, 20 (03) : 491 - 496
[35] The assessment and management of insomnia in primary care
Falloon, Karen
Arroll, Bruce
Elley, C. Raina
Fernando, Antonio, III
BMJ-BRITISH MEDICAL JOURNAL, 2011, 342
[36] Use of Influenza Antiviral Agents by Ambulatory Care Clinicians During the 2012-2013 Influenza Season
Havers, Fiona
Thaker, Swathi
Clippard, Jessie R.
Jackson, Michael
McLean, Huong Q.
Gaglani, Manjusha
Monto, Arnold S.
Zimmerman, Richard K.
Jackson, Lisa
Petrie, Josh G.
Nowalk, Mary Patricia
Moehling, Krissy K.
Flannery, Brendan
Thompson, Mark G.
Fry, Alicia M.
CLINICAL INFECTIOUS DISEASES, 2014, 59 (06) : 774 - 782
[37] Management of knee osteoarthritis in primary care
Sim, Hui Shan
Ang, Ke Xin Magneline
How, Choon How
Loh, Sir Young James
SINGAPORE MEDICAL JOURNAL, 2020, 61 (10) : 512 - 515
[38] Recommendations for the allergy management in the primary care
Jutel, M.
Papadopoulos, N. G.
Gronlund, H.
Hoffman, H. -J.
Bohle, B.
Hellings, P.
Braunsthal, G. -J.
Muraro, A.
Schmid-Grendelmeier, P.
Zuberbier, T.
Agache, I.
ALLERGY, 2014, 69 (06) : 708 - 718
[39] COPD Management in the Primary Care Setting
Skolnik, Neil
Kaplan, Alan G.
Lake, Tiffany
Hayden, Mary Lou
Hanania, Nicola A.
JOURNAL OF FAMILY PRACTICE, 2018, 67 (10) : S27 - S32
[40] Problems of case and disease management in outpatient treatment of influenza
Kossow, KD
MEDICAL MICROBIOLOGY AND IMMUNOLOGY, 2002, 191 (3-4) : 129 - 132

← 1 2 3 4 5 →